Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 11 of 11 for “"CFTR modulator therapy"”.
-
The Impact of CFTR Modulator Therapy on Exercise Intolerance and Oxygen Transport Metabolism in Cystic Fibrosis
… now have access to novel pharmacological “modulator therapies” that improve pulmonary function by directly targeting the cystic fibrosis transmembrane regulator (CFTR) protein defect. However, the impact of these therapies on other organ systems and exercise tolerance remains unknown. This …
-
EFFECTS OF SHIFTING CYSTIC FIBROSIS THERAPIES ON SURVIVAL AND CYSTIC FIBROSIS-RELATED DIABETES
… Fibrosis transmembrane conductance regulator (CFTR) modulator therapies revolutionized treatment for people with cystic fibrosis (CF), but their effect on death and CF-related diabetes diagnosis has not been fully described. Furthermore, the changing therapeutic landscape complicates the …
-
Lung repair in cystic fibrosis
… fibrosis transmembrane conductance regulator (CFTR) ion channels effecting flow of chloride, bicarbonate and water out of cells. This causes thick mucus with repeated bacterial infections and a decrease in lung function. CFTR modulator therapies have shown variable improvements in lung function …
-
Cistinė fibrozė. Klinikinio atvejo aprašymas /
… patient in Lithuania, who received the latest CFTR modulator therapy for cystic fibrosis. The analysis utilizes the patient's medical data collected between 2017 and 2024.
-
Metabolic, Inflammatory, and Microbial Factors Shaping Organ Health in CF
… lung function, and to evaluate the impact of CFTR modulator therapy on hepatobiliary involvement in children with CF.Methods: Paper I and II were observational studies focusing on airway inflammation (Meso Scale Discovery assays and chromogenic assays), sputum proteomics (tandem mass …
-
Cellular Metabolism and the NLRP3 Inflammasome as Therapeutic Targets in Cystic Fibrosis
… is caused by mutations in the gene encoding the CFTR protein, an anion channel that conducts Cl- and HCO3- and regulates amiloride-sensitive Na+ channels. In both animal and in vitro models, CFTR dysfunction results in excessive neutrophilic inflammation, Na+ absorption and inflammasome …
-
Risk of weight gain due to the consumption of ultra-processed foods or Cystic Fibrosis Transmembrane Conductance Regulator modulator intake
… (UPF) and the use of a novel pharmacological therapy in people with Cystic Fibrosis (CF). Strategies to address these risks include protein fortification of UPF and rehabilitation programmes combining exercise and dietary counselling for people with CF, who often have poor diet quality. The …
-
Fungi in the Lungs of People with Cystic Fibrosis: Immune Response and The Airway Mycobiome
… in relation to lung disease severity as well as CFTR modulator therapy. Third, the impact of antifungals on the lung mycobiome was investigated in a longitudinal study where sputum samples from before and during/post treatment were analysed. Asp f1 and f2 antigens were associated with Aspergillus …
-
Applications of machine learning in chronic respiratory infection
… function, as well as assessing the impact of CFTR modulators on cardiovascular risk and inflammatory markers using a large CF EHR dataset; and (iii) apply artificial intelligence (AI) to a database of surface-enhanced Raman spectroscopy (SERS) signals from cultured bacterial samples to develop …
-
Cystic fibrosis. literature analysis /
… fibrosis, focusing on the effects of modern CFTR modulators. Cystic fibrosis is a genetic disorder caused by mutations in the CFTR gene, leading to impaired chloride and bicarbonate transport, excessive mucus production, and progressive organ damage, particularly in the lungs. Progressive …
-
Potentiating CFTR function attenuates platelet activation and aggregation in blood of coronavirus disease 2019 (COVID-19) patients and healthy donors
… fibrosis transmembrane conductance regulator (CFTR) functions as both a chloride (Cl−) channel and an ATP-binding cassette (ABC) transporter. Its mutation drives cystic fibrosis (CF) pathogenesis by disrupting osmotic fluid balance across epithelial membranes. In addition to its central role in …